Bone metastases

  • 30% of patients with malignant disease will develop bone metastases
  • 10% of these patients will develop a pathological fracture
  • Tumours spread to bone by:
    • Direct invasion
    • Haematogenous spread
    • Lymphatic spread
    • Spread via paravertebral venous plexus
  • Commonest sites lumbar vertebrae, pelvis and ribs

Primary tumours which spread to bone

  • Breast  (35%)
  • Prostate  (30%)
  • Bronchus (10%)
  • Kidney  (5%)
  • Thyroid  (2%)
  • Others (18%)

Clinical features

  • Pain or localised bone lump
  • Pathological fracture
  • Hypercalcaemia
  • Cord compression

Radiology

  • Plain x-rays can be normal
  • If abnormal will show either an osteolytic or sclerotic lesion

Multiple bone metastases secondary to breast carcinoma

  • Bone scan has higher sensitivity than x-rays
  • May identify other asymptomatic lesions

A bone scan showing multiple 'hot spots' consistent with extensive metastatic disease

Differential diagnosis

  • Calcified enchondroma
  • Hyperparathyroidism
  • Chronic sclerosing osteomyelitis
  • Bone infarct
  • Myeloma deposit

Treatment

  • The aims of treatment are to relieve pain and preserve mobility
  • If pathological fracture consider internal fixation for early mobilisation and pain relief
  • Consider radiotherapy for back pain
  • Spinal decompression may be needed for cord compression
  • Prophylactic internal fixation may be required if:
    • Greater than 50% erosion of a long bone cortex
    • A metastasis of more than 2.5 cm in diameter
    • Metastasis in high risk area (e.g. subtrochanteric femur)
    • Metastasis with persistent pain

Bibliography

British Association of Surgical Oncology Guideline.  The management of metastatic bone disease in the United Kingdom.  The Breast Speciality Group of the British Association of Surgical Oncology.  Eur J Surg Oncol 1999;  25:  3-23.

Downey S E,  Bundred N J.  Bone metastases.  In:  Johnson C D,  Taylor I eds.  Recent advances in surgery 19.  Churchill Livingstone, Edinburgh 1996;  109-128.

Major P P,  Cook R.  Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical end-points.  Am J Clin Oncol 2002;  25 (Suppl1);  S10-S18.

Radford M,  Gibbons C L.  Management of skeletal metastases.  Hosp Med 2002;  63:  722-725

Rosenthal D I.  Radiologic diagnosis of bone metastases.  Cancer 1997;  80 (Suppl 8):  1595-1607.

Ryan P J.  Fogelman I.  The bone scan:  where are we now?  Semin Nucl Med 1995;  25:  76-91.

 

 
 

Copyright © 1997- 2012 Surgical-tutor.org.uk